Table 4.
Humira Patent Families.
| Patented subject matter and earliest granted family member | # of granted U.S. patents | # of granted U.S. Patents linked by terminal disclaimers |
|---|---|---|
| Basic product patent US6090382 | 10 | 10 |
| Primary indications US8889135 | 7 | 4 |
| Formulation (single concentration) US8216583 | 21 | 21 |
| Secondary indications US8889136 | 18 | 15 |
| Purity level US8916153 | 8 | 8 |
| Treatment of hidradenitis suppurativa US8747854 | 2 | 2 |
| Treatment of juvenile diseases US8999337 | 3 | 3 |
| Formulation (double concentration) US8420081 | 4 | 4 |